| |
| |
|
| Insider
Information: |
Peraza Lisa |
| Relationship: |
VP, Chief Accounting O... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
55,907 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$136,972 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
55,907 |
|
|
| Total
Value |
$136,972 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Heron Therapeutics Inc |
HRTX |
VP, Chief Accounting O... |
2024-01-13 |
55,907 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2024-01-13 |
4 |
D |
$2.15 |
$1,625 |
D/D |
(756) |
55,907 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2024-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,841 |
56,663 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2023-10-13 |
4 |
D |
$0.72 |
$619 |
D/D |
(860) |
54,822 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2023-10-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,484 |
55,682 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2023-07-25 |
4 |
D |
$1.51 |
$22,262 |
D/D |
(14,743) |
53,198 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2023-07-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
42,631 |
67,941 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2023-07-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,485 |
26,170 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2023-07-13 |
4 |
D |
$1.31 |
$1,127 |
D/D |
(860) |
25,310 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2023-04-13 |
4 |
D |
$2.88 |
$2,477 |
D/D |
(860) |
23,685 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2023-04-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,484 |
24,545 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2023-01-13 |
4 |
D |
$3.17 |
$3,211 |
D/D |
(1,013) |
22,061 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2023-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,485 |
23,074 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2022-10-13 |
4 |
D |
$3.76 |
$3,237 |
D/D |
(861) |
20,589 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2022-10-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,485 |
21,450 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2022-07-13 |
4 |
D |
$3.01 |
$2,589 |
D/D |
(860) |
18,965 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2022-07-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,485 |
19,825 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2022-01-13 |
4 |
D |
$8.30 |
$8,018 |
D/D |
(966) |
15,716 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2022-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,485 |
16,682 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2021-10-13 |
4 |
D |
$10.55 |
$2,015 |
D/D |
(191) |
14,197 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2021-10-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
552 |
14,388 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2021-07-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
552 |
14,027 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2021-07-13 |
4 |
D |
$13.48 |
$2,575 |
D/D |
(191) |
13,836 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2021-04-30 |
4 |
A |
$13.90 |
$21,263 |
D/D |
1,530 |
13,475 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2021-04-13 |
4 |
D |
$16.66 |
$3,182 |
D/D |
(191) |
11,945 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
VP, Chief Accounting Officer |
• – – |
2021-04-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
552 |
12,136 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
